Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series

Clinical Lung Cancer(2023)10.1016/j.cllc.2023.08.006Source: DataRank Database

Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series is a research paper published in Clinical Lung Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 2.63)OA: bronzeTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Joshua Wang ORCID,N Gallego,Isa Mambetsariev ORCID,Pauline Kim,Razmig Babikian

Live enrichment

PubMed:37580188 OpenAlex:https://openalex.org/W4385611799

National Cancer Institute

Grant: P30CA033572

FWCI

2.63

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc/4.0/

journalhttp://www.clinical-lung-cancer.com/article/S1525730423001511/pdf

publisherhttp://www.clinical-lung-cancer.com/article/S1525730423001511/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525730423001511?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525730423001511?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cllc.2023.08.006

Fields of Study

Lymphoma Diagnosis and TreatmentGastrointestinal disorders and treatmentsLymphatic Disorders and TreatmentsHumansChylous AscitesLung NeoplasmsPyrazolesProtein Kinase InhibitorsProto-Oncogene Proteins c-retPyridinesPyrimidines

MeSH Terms

Chylous AscitesHumansLung NeoplasmsPyrazolesPyridinesPyrimidinesProtein Kinase InhibitorsProto-Oncogene Proteins c-ret

Keywords

MedicineLung cancerAdenocarcinomaOncologyInternal medicineCrizotinibCancerCancer researchPrecision medicineTargeted therapyToxicity managementTreatment response

Sustainable Development Goals

SDG 0: Good health and well-being